SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CECONI, Claudio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.800
EU - Europa 4.589
AS - Asia 2.698
SA - Sud America 27
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 3
Totale 24.138
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.765
IT - Italia 1.716
CN - Cina 1.468
UA - Ucraina 1.222
TR - Turchia 565
DE - Germania 547
SG - Singapore 544
GB - Regno Unito 433
FI - Finlandia 280
SE - Svezia 175
FR - Francia 67
ID - Indonesia 35
PL - Polonia 33
CA - Canada 26
BR - Brasile 17
ES - Italia 16
RU - Federazione Russa 15
VN - Vietnam 15
AU - Australia 14
IN - India 13
BE - Belgio 11
NL - Olanda 11
CZ - Repubblica Ceca 9
GE - Georgia 8
HK - Hong Kong 8
KR - Corea 8
MX - Messico 8
LT - Lituania 7
RO - Romania 7
CH - Svizzera 6
IR - Iran 6
JP - Giappone 6
PT - Portogallo 6
TW - Taiwan 6
AL - Albania 5
EU - Europa 5
IE - Irlanda 5
CL - Cile 4
CO - Colombia 4
AT - Austria 3
GR - Grecia 3
HR - Croazia 3
IL - Israele 3
AM - Armenia 2
BG - Bulgaria 2
EG - Egitto 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
HU - Ungheria 1
MD - Moldavia 1
MM - Myanmar 1
PE - Perù 1
QA - Qatar 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 24.138
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.374
Fairfield 2.367
Houston 1.349
Jacksonville 1.347
Ashburn 1.042
Seattle 985
Chandler 887
Ann Arbor 886
Wilmington 799
Cambridge 795
Santa Clara 456
Izmir 432
Nanjing 410
Singapore 398
Princeton 349
San Diego 232
Boardman 189
Beijing 147
Shenyang 135
Milan 131
Nanchang 119
Rome 97
Hebei 81
New York 79
San Mateo 76
Los Angeles 71
Changsha 70
Falls Church 68
Ferrara 67
Jiaxing 66
Tianjin 58
Jinan 57
Mountain View 47
Shanghai 47
Naples 43
Verona 42
Zhengzhou 41
Ningbo 39
Bremen 38
London 38
Redwood City 37
Taizhou 36
Philadelphia 30
Warsaw 30
Jakarta 29
Norwalk 27
Addison 25
Tappahannock 25
Napoli 24
Indiana 22
Kunming 20
Des Moines 18
Orange 18
Bari 17
Chicago 17
Guangzhou 17
Helsinki 17
Washington 17
Hangzhou 16
Bologna 15
Frankfurt am Main 15
Lappeenranta 15
Dearborn 14
Dong Ket 14
Florence 14
Genova 14
Palermo 14
Toronto 14
Turin 14
Changchun 11
Kilburn 11
Munich 11
Padova 11
Redmond 11
Brescia 10
Brussels 10
Cagliari 9
Torino 9
Catania 8
Olomouc 8
Tbilisi 8
Yellow Springs 8
Auburn Hills 7
Haikou 7
Lanzhou 7
Pisa 7
Genoa 6
Hounslow 6
Hualien City 6
Modena 6
Taranto 6
Caserta 5
Como 5
Fuzhou 5
Livorno 5
Monmouth Junction 5
Ottawa 5
Pozzo Di Gotto 5
Sheffield 5
Siena 5
Totale 17.767
Salva come PNG Salva come JPEG
Nome #
IL METABOLISMO DEL MIOCARDIO ISCHEMICO IBERNATO E STORDITO: DIFFERENZA TRA NECROSI E APOPTOSI 1.700
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 176
Effects of temperature on myocardial calcium homeostasis and mitochondrial function during ischemia and reperfusion. 158
Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL 150
Echocardiography, Spirometry, and Systemic Acute-Phase Inflammatory Proteins in Smokers with COPD or CHF: An Observational Study 150
Uric acid and coronary artery disease: An elusive link deserving further attention 142
Enhanced expression and activity of xanthine oxidoreductase in the failing heart. 141
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 138
The combined effect of subcutaneous granulocyte- colony stimulating factor and myocardial contrast echocardiography with intravenous infusion of sulfur hexafluoride on post-infarction left ventricular function, the RIGENERA 2.0 trial: Study protocol for a randomized controlled trial 136
2015 ESC Guidelines for the diagnosis and management of pericardial diseases The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS) 136
Guidelines on myocardial revascularization 133
Prolonged propionyl-L-carnitine pre-treatment of rabbit: biochemical, hemodynamic and electrophysiological effects on myocardium. 133
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). 128
Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy 123
Abnormalities of left ventricular function in asymptomatic patients with systemic sclerosis using doppler measures of myocardial strain. 122
A way forward to the elimination of conflict of interest for experts involved in regulatory medicine and guidelines 122
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes 121
A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals 121
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 120
Time course of human atrial natriuretic factor release during cardiopulmonary bypass in mitral valve and coronary artery diseased patients. 119
Third Universal Definition of Myocardial Infarction 119
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes (Am Journal of Cardiovasc Drugs (2011) 11:3 (189-98)) 118
Is stunning an important component of preconditioning? 117
Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD 117
Reduction of oxidative stress by carvedilol: role in maintenance of ischaemic myocardium viability. 116
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation * Developed with the special contribution of the European Heart Rhythm Association. 116
Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) 116
Incremental exercise using progressive versus constant pedaling rates: A study in cardlac patients 115
Postinfarction Left Ventricular Free Wall Rupture: Original Management and Surgical Technique 114
Tumor necrosis factor in congestive heart failure: a mechanism of disease for the new millennium? 114
Long-term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression 114
Link between chronic obstructive pulmonary disease and coronary artery disease: Implication for clinical practice 113
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation 113
Effects of endotoxic shock on neuronal NOS and calcium transients in rat cardiac myocytes 113
Occurrence of oxidative stress during reperfusion of the human heart. 112
In vitro administration of ergothioneine failed to protect isolated ischaemic and reperfused rabbit heart 112
Traditional and new composite endpoints in heart failure clinical trials: Facilitating comprehensive efficacy assessments and improving trial efficiency 112
Heart rate reduction with ivabradine prevents the global phenotype of left ventricular remodeling. 111
Relevance of apoptosis in influencing recovery of hibernating myocardium 111
Right heart failure chronically stimulates heat shock protein 72 in heart and liver but not in other tissues. 111
Effects of iloprost (ZK 36374) on glutathione status during ischaemia and reperfusion of rabbit isolated hearts 110
Specific properties and effect of perindopril in controlling the renin-angiotensin system. 110
Differences in the effect of angiotensin-converting enzyme inhibitors on the rate of endothelial cell apoptosis: in vitro and in vivo studies 109
Oxygen Free Radicals in Shock 109
Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE 109
Oxygen free radicals and myocardial damage: protective role of thiol-containing agents. 108
Effect of superoxide generation on rat heart mitochondrial pyruvate utilization 108
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC 108
Revascularization of hibernating myocardium: rate of metabolic and functional recovery and occurrence of oxidative stress. 107
Different outcomes of the reperfused myocardium: insights into the comments of stunning and hibernation. 107
Changes in oxidative stress and cellular redox potential during myocardial storage for transplantation: Experimental studies 107
ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). 107
Plasma levels of atrial natriuretic factor and urinary excretion of arginine vasopressin and catecholamines in children with congenital heart disease effect of cardiac surgery 106
null 106
The ACE-inhibitor Perindoprilat has high selectivity for bradykinin binding sites of human somatic ACE 106
Pathophysiological role of heart rate: from ischaemia to left ventricular dysfunction 106
Selective and specific I f inhibition with ivabradine: New perspectives for the treatment of cardiovascular disease 106
Secondary Prevention of CAD with ACE Inhibitors: A Struggle Between Life and Death of the Endothelium 106
null 106
New insights on myocardial pyridine nucleotides and thiol redox state in ischemia and reperfusion damage 105
Noradrenaline, atrial natriuretic peptide, bombesin and neurotensin in myocardium and blood of rats in congestive cardiac failure. 105
Potential prognostic significance of decreased serum levels of TRAIL after acute myocardial infarction 105
Metabolic adaptation during a sequence of no-flow and low-flow ischemia. A possible trigger for hibernation. 104
Oxygen free radicals and reperfusion injury; the effect of ischaemia and reperfusion on the cellular ability to neutralise oxygen toxicity 104
Anti-ischaemic effect of ivabradine 104
Efficacy of Ivabradine in Combination with Beta-Blocker Versus Uptitration of Beta-Blocker in Patients with Stable Angina 104
Left ventricular dysfunction due to stunning and hibernation in patients. 103
Myocardial damage during ischaemia and reperfusion. 103
Chromogranin A in heart failure - A novel neurohumoral factor and a predictor for mortality 103
Third universal definition of myocardial infarction 103
Improved exercise tolerance after losartan and enalapril in heart failure: correlation with changes in skeletal muscle myosin heavy chain composition 103
Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review 103
Anti-ischemic effect of IVA in isolated rabbit hearts: Modulation of cardiac metabolism 103
Protective effect of propionyl-L-carnitine against ischaemia and reperfusion-damage. 102
Mechanical vs. electrical dyssynchrony for CRTselection in patients with HF 102
Role of A2A receptor in the modulation of myocardial reperfusion damage. 102
Evidence against malondialdehyde bound to cellular constituents in phospholipid peroxidation 102
Protective effect of a prostacyclin-mimetic on the ischaemic-reperfused rabbit myocardium. 101
One heart, two lungs together forever 101
Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). 101
Activation of the neuroendocrine response in heart failure: adaptive or maladaptive process? 101
Specific and selective I-f inhibition: expected clinical benefits from pure heart rate reduction in coronary patients 101
ACE inhibition with perindopril and biomarkers of atherosclerosis and thrombosis: Results from the PERTINENT study 101
Effects of felodipine on the ischemic heart: insight into the mechanism of cytoprotection. 100
Lipid peroxidation in normal pregnancy and preeclampsia 100
Cardioprotection by nisoldipine: role of timing of administration. 100
Skeletal muscle abnormalities in rats with experimentally induced heart hypertrophy and failure. 100
Oxidative stress during myocardial ischaemia and heart failure. 100
The influence of right heart catheterisation on pulmonary arterial pressure in chronic heart failure: relationship to neuroendocrinal changes 100
The effect of propionyl-L-carnitine on the ischemic and reperfused intact myocardium and on their derived mitochondria. 100
Metabolic changes during post-ischaemic reperfusion. 100
The ACE-inhibitor perindoprilat has high selectivity for bradykinin binding sites of human somatic ACE 100
Differential action of ACE inhibitors on the eNOS pathway 100
Effect of L-carnitine derivatives on heart mitochondrial damage induced by lipid peroxidation. 100
The role of glutathione status in the protection against ischaemic and reperfusion damage: effects of N-acetyl cysteine. 100
The occurrence of oxidative stress during reperfusion in experimental animals and men. 99
Third Universal Definition of Myocardial Infarction 99
Ace inhibition with perindopril and markers of atherosclerosis and thrombosis: Results of the pertinent study 99
Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease 99
Myocardial recovery during post-ischaemic reperfusion: effects of nifedipine, calcium and magnesium. 98
Totale 12.754
Salva come PNG Salva come JPEG
Categoria #
all - tutte 99.899
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.660
Totale 104.559
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.344 0 0 0 0 419 606 454 585 418 577 165 120
2020/20213.361 295 343 198 452 178 362 78 437 76 438 353 151
2021/20222.999 85 374 306 82 107 137 167 151 100 187 262 1.041
2022/20232.315 277 29 78 259 391 382 52 243 315 24 152 113
2023/20241.176 178 166 77 50 66 130 48 31 18 64 56 292
2024/20251.159 83 106 341 104 525 0 0 0 0 0 0 0
Totale 24.384